January 2023 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2024 Concepts

FY 2024 Small Business Innovation Research (SBIR) Contract Solicitation Topics

Bioinformatics Resource Centers (BRCs) for Infectious Diseases

For the published request for applications, check the May 15, 2023 Guide notice, Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed).

Animal Models for Hepatitis B and C

For the published request for applications, check the March 28, 2023, Guide announcement, Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed).

Collaborative Partnership to Advance Global Health Research

For the published program announcement with special receipt, referral, and/or review considerations, check the June 5, 2023 Guide announcement, Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed).

International Research in Infectious Diseases

For the published request for applications, check the April 14, 2023 Guide announcement, International Research in Infectious Diseases (R01, Clinical Trial Not Allowed). 

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae, and Picornaviridae

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed).

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed).

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC)

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed).

Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics

For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics.

Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)

For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs).

Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector

For the published notice of special interest, check the October 3, 2022 Guide notice, Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector.

Alternatives to Benzathine Penicillin for Treatment of Syphilis

For the published request for proposals, check the August 25, 2023 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.

Development of Bacteriophage for Treatment of Mycobacterial Infections

For the published request for proposals, check the August 25, 2023 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.

Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections

For the published request for proposals, check the August 25, 2023 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.

Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)

For the published request for proposals, check the August 25, 2023 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.

Content last reviewed on